祖拉诺治疗产后抑郁症的临床效用:叙述性综述
Athanasia Giannopoulos1, Joshna Singh2, Kristina M Deligiannidis1,3
1Division of Psychiatry Research, Zucker Hillside Hospital, Northwell Health, New York, NY, USA.
Neuropsychiatric disease and treatment
|January 30, 2025
概括
祖拉诺为周周抑郁症 (PPD) 提供了一种新的口服治疗方法,在临床试验中显示出迅速改善症状. 这种神经活性类固醇抗抑郁药通常耐受良好,对母亲的焦虑和失眠有潜在的益处.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 产前抑郁症 (PPD) 影响8个个体中的1个,往往仍未得到确诊和治疗.
- 现有的治疗方法包括心理治疗,传统抗抑郁药和替代医学.
- 基于神经活性类固醇的抗抑郁药是一种新的治疗类.
研究的目的:
- 审查Zuranolone的临床实用性,一种新的口服抗抑郁药用于PPD.
- 总结了从临床试验中关于祖拉诺的疗效和安全性的证据.
- 讨论PPD管理的临床决策.
主要方法:
- 临床试验的叙述性审查.
- 双盲,随机,安慰剂对照研究的分析.
- 评估安全性,有效性和生活质量的结果.
主要成果:
- 祖拉诺在抑郁症状方面表现出快速,显著和临床上有意义的改善.
- 常见的副作用包括嗜睡,头,镇静和头痛.
- 没有观察到对生命体征,心电图或实验室参数的显著不良影响;没有增加自杀念头.
结论:
- 祖拉诺是第一个FDA批准的口服抗抑郁药,用于患有PPD的成年女性.
- 它在改善PPD,焦虑,失眠和生活质量方面表现出有效性.
- 哺乳期数据表明与母乳养的兼容性,需要进一步研究.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
183
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
183
Psychosis: Goals of Pharmacotherapy
103
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
103
Anxiolytic Drugs: Benzodiazepines and Buspirone
480
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
480
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
173
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
173
Sedatives and Hypnotics Drugs: Miscellaneous Agents
144
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
144
CNS Depressants: Barbiturates and Benzodiazepines
215
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
215


